Excell Partners
VC Fund
Rochester, United States
Excell Partners is a VC fund in Rochester focused on Health Care and Biotechnology. Excell is a New York State-supported seed fund. Although it is a not-for-profit organization, Excell maintains a for-profit discipline by structuring each investment with convertible debt and equity returns so that, over time, the fund becomes self-sustaining or evergreen.
- Total investments:
- 40
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Excell Partners invests in
Stages Excell Partners invests in
Countries Excell Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $100k–$2.2M
- Series A
- $1.2M–$20M
Investment Focus
Industry
- Health Care 12 (30%)
- Biotechnology 10 (25%)
- Software 6 (15%)
- Manufacturing 6 (15%)
- Energy 4 (10%)
Stage
- Seed 21 (53%)
- Series A 8 (20%)
- Funding Round 3 (8%)
- Venture - Series Unknown 3 (8%)
- Series D 1 (3%)
Country
- United States 34 (85%)
- Israel 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Christopher Kaufman
Venture Analyst
|
Venture Analyst | Total investments: 0 | Find email | |
|
James Watters
Director
|
Director | Total investments: 0 | Find email | |
|
J. Montieth Estes
Director
|
Director | Total investments: 0 | Find email | |
|
Maggie Brooks
Director
|
Director | Total investments: 0 | Find email | |
|
Mary Ann Tyszko
Director
|
Director | Total investments: 0 | Find email | |
| See all 17 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ognomy Sleep
|
Ognomy Sleep provides virtual sleep apnea care services that connect patients with sleep medicine specialists through telehealth appointments, home-based sleep testing, and ongoing treatment support. The company offers a digital care platform designed to help diagnose and manage sleep apnea through consultations, at-home evaluations, andpersonalized therapy options. Ognomy Sleep supports treatments such as PAP therapy, oral appliance therapy, Inspire implant therapy, and weight management options related to sleep apnea care. The platform also works with healthcare providers through referral services that support patient coordination and follow-up care. | $20M / Series A / Jun 30, 2026 | |
Thread
|
Thread specializes in enterprise-scale autonomous data collection that delivers precise inspection insights. Its suite of tools empowers users to programmatically capture knowledge into consistent and replicable plans. Any visual inspection activity being performed by a pilot in GPS-accessible locations today can be automated through Airtonomy.These tools can be used to make full end-to-end automated workflows as they have done with its wind product. | $15M / Series A / Oct 10, 2023 | |
Neurogenesis
|
Neurogenesis develops an approach to sustained delivery of remyelinating & regeneration proteins using the patient’s own stem cells. The technology is called NG CELL™. It entails collecting bone marrow from the patient. | Series A / Mar 11, 2022 | |
OWL Autonomous Imaging
|
Owl Autonomous Imaging delivers Monocular 3D Thermal Ranging™ solutions to industrial and automotive mobility markets to dramatically enhance safety day or night and in all weather conditions. Thermal Ranging™ is a new 3D modality that uses optical fusion and novel deep learning techniques to extract dense range maps from radiated heat signatures,without requiring illumination.Owl was co-founded by Chuck Gershman. Mr. Gershman has 30 years of semiconductor industry experience in executive management, marketing, engineering, business development, sales, consulting and executive advising. A serial entrepreneur, Mr. Gershman has been a member of the executive team of five startups, three of which as CEO/COO. He has had successful exits with acquisitions by Intel and PMC-Sierra. Further company information can be found at www.owlai.us | $15M / Series A / Jan 25, 2022 | |
SunDensity
|
SunDensity has developed a groundbreaking Photonic Smart Coating (PSC™) technology that enables the up and down conversion of the wavelengths in white light (UV to IR) to match the desired band which can solve several in-efficiencies in photonics. By conversion of spectrum, they have developed, and field tested a patent-pending PSC™ thatsignificantly reduces the cost of electricity generated by solar photovoltaics (PV) applications, customizes thermal and optical behavior of architectural glass, and increases the quantum efficiency of optoelectronic instruments. | Venture - Series Unknown / Dec 21, 2021 | |
Conamix
|
Conamix is commercializing new low-cost high-energy materials for the global lithium-ion battery market. The company’s materials are designed to drop-in to existing manufacturing infrastructure to both improve the energy density and lower the cost of lithium-ion systems. Founded in 2014, the company is led by an experienced team of chemical andbattery industry leaders and has intellectual property agreements with multiple leading global research institutions. | $4M / Venture - Series Unknown / Nov 24, 2021 | |
RealEats
|
RealEats is a food tech company that offers a premium meal prep delivery service. Its first product innovation is a line of healthy hyper-convenient meals that reduce food waste. RealEats meals are delivered directly to consumers. Its products are chef-designed, nutritionally rich, and made from whole, unprocessed, responsibly sourced, junk-freeingredients, many of which are from local farms in the Finger Lakes agricultural region of New York State where the company's kitchen is located. | $16.3M / Series A / Oct 26, 2021 | |
Soos Technology
|
SOOS develops an incubation system that affects the sex development process in poultry embryo and turns genetic males into functional female chicks.The company's solution is an incubation system (AI-driven software controlling a customized incubation cell) that controls the sex development process in chicken embryos and uses genetic malelayers to produce functional female layers that can lay eggs. | $6M / Series A / Mar 01, 2021 | |
Casana
|
Casana is unlocking a new category in healthcare technologies that enable effortless, integrated and consistent in-home heart health monitoring. Casana’s first product, The Heart Seat™ is an IoT heart health toilet seat that captures clinically relevant measurements, including heart rate, blood pressure, blood oxygenation, and cardiac output.Casana’s mission is to assist medical teams in their care management of patients with chronic conditions beyond the four walls of the hospital, starting with the 6M+ people in the US living with Heart Failure. | $2.2M / Seed / Apr 01, 2020 | |
VPG Medical
|
VPG Medical is a digital health service company developing a unique set of monitoring solutions based on groundbreaking research using video-based sensors embedded in smart devices and personal computers.The company is dedicated to providing effortless monitoring solutions to improve the lives of patients requiring continuous monitoring of theirhealth status. | $25K / Venture - Series Unknown / Feb 07, 2020 | |
| See all 40 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Excell Partners invest in?
Excell Partners invests primarily in Health Care, Biotechnology and Software startups, most often at Seed and Series A stage. Most of the 40 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Excell Partners's check size?
Excell Partners typically joins rounds of $100k–$2.2M at Seed and $1.2M–$20M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Excell Partners participates in.
How do I contact Excell Partners?
Public channels for Excell Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Excell Partners?
The team at Excell Partners includes Christopher Kaufman (Venture Analyst), James Watters (Director) and J. Montieth Estes (Director), among 17 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
